Table 4 Cox regression analysis after initiation of enteral feeding and parenteral nutrition
Non-malignancies | Malignancies | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
Hazard ratio | 95% CI | p | Hazard ratio | 95% CI | p | |||||
Gender | ||||||||||
Male | 1.61 | 1.47 | – | 1.77 | < 0.001 | 1.16 | 0.96 | – | 1.39 | 0.124 |
Female | Reference | – | – | – | Reference | – | – | – | ||
Age | ||||||||||
≥ 85 | 1.48 | 1.34 | – | 1.62 | < 0.001 | 1.43 | 1.18 | – | 1.74 | < 0.001 |
76–84 | Reference | – | – | – | Reference | – | – | – | ||
Comorbidities (CCI) | ||||||||||
0–1 | 0.86 | 0.75 | – | 0.99 | 0.029 | – | – | – | – | |
2–3 | 1.07 | 0.94 | – | 1.22 | 0.286 | 0.68 | 0.57 | – | 0.82 | < 0.001 |
≥ 4 | Reference | – | – | – | Reference | – | – | – | ||
Hospital type | ||||||||||
DPC | 0.85 | 0.75 | – | 0.95 | 0.007 | 0.84 | 0.67 | – | 1.05 | 0.121 |
Non-DPC | Reference | – | – | – | Reference | – | – | – | ||
Hospital beds | ||||||||||
≥ 200 | 1.03 | 0.91 | – | 1.17 | 0.654 | 1.04 | 0.79 | – | 1.36 | 0.79 |
< 200 | Reference | – | – | – | Reference | – | – | – | ||
Hospital area | ||||||||||
Capital city | 0.68 | 0.55 | – | 0.86 | 0.001 | 1.13 | 0.73 | – | 1.77 | 0.583 |
Eastern | 0.62 | 0.50 | – | 0.78 | < 0.001 | 1.23 | 0.77 | – | 1.98 | 0.392 |
Western | 0.82 | 0.66 | – | 1.03 | 0.084 | 1.13 | 0.71 | – | 1.78 | 0.61 |
Central | 0.70 | 0.55 | – | 0.87 | 0.002 | 1.13 | 0.73 | – | 1.75 | 0.581 |
Southern | Reference | – | – | – | Reference | – | – | – | ||
Enteral feeding and parenteral nutrition | ||||||||||
Secondary GS | 0.43 | 0.34 | – | 0.54 | < 0.001 | 0.42 | 0.28 | – | 0.64 | < 0.001 |
Primary GS | 0.51 | 0.40 | – | 0.64 | < 0.001 | 0.46 | 0.32 | – | 0.68 | < 0.001 |
NGT | 0.71 | 0.58 | – | 0.87 | 0.001 | 0.66 | 0.54 | – | 0.80 | < 0.001 |
PN | Reference | – | – | – | Reference | – | – | – | ||